VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,383 | -56.1% | 361 | -9.8% | 0.00% | – |
| Q2 2023 | $7,710 | +175.0% | 400 | +100.0% | 0.00% | – |
| Q1 2023 | $2,804 | +70000.0% | 200 | -10.3% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 223 | +11.5% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -50.0% | 200 | -50.0% | 0.00% | – |
| Q1 2022 | $6,000 | -25.0% | 400 | +100.0% | 0.00% | – |
| Q4 2021 | $8,000 | -11.1% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | -66.7% | 200 | -66.2% | 0.00% | -100.0% |
| Q2 2021 | $27,000 | -18.2% | 591 | -11.3% | 0.00% | 0.0% |
| Q1 2021 | $33,000 | +120.0% | 666 | +9.9% | 0.00% | 0.0% |
| Q4 2020 | $15,000 | -6.2% | 606 | +28.7% | 0.00% | 0.0% |
| Q3 2020 | $16,000 | +128.6% | 471 | +135.5% | 0.00% | 0.0% |
| Q2 2020 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |